AR047440A1 - PRODUCTION OF A MONOCLONAL ANTIBODY IN A HETEROCARION FUNGI OR A FUNGAL GUEST CELL - Google Patents

PRODUCTION OF A MONOCLONAL ANTIBODY IN A HETEROCARION FUNGI OR A FUNGAL GUEST CELL

Info

Publication number
AR047440A1
AR047440A1 ARP050100209A ARP050100209A AR047440A1 AR 047440 A1 AR047440 A1 AR 047440A1 AR P050100209 A ARP050100209 A AR P050100209A AR P050100209 A ARP050100209 A AR P050100209A AR 047440 A1 AR047440 A1 AR 047440A1
Authority
AR
Argentina
Prior art keywords
nucleic acid
acid sequence
sequence encoding
antibody
heterocarion
Prior art date
Application number
ARP050100209A
Other languages
Spanish (es)
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of AR047440A1 publication Critical patent/AR047440A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se refiere a métodos para producir un anticuerpo monoclonal en un hongo heterocarion o en una célula huésped fungal. Además, se refiere también a una construccion de ácido nucleico, a una primera secuencia de ácido nucleico que codifica para una cadena liviana de un anticuerpo, y a una tercera secuencia de ácido nucleico que codifica para un péptido de senalizacion heterologo para la primera secuencia de ácido nucleico, una construccion de ácido nucleico que comprende una primera secuencia de ácido nucleico que codifica para una cadena pesada de un anticuerpo y una tercera secuencia de ácido nucleico que codifica para un péptido de senalizacion heterologo de la primera secuencia de ácido nucleico, una construccion de ácido nucleico que comprende una primera secuencia de ácido nucleico que codifica para una cadena liviana de un anticuerpo y una segunda secuencia de ácido nucleico que codifica para una dominio de union a celulosa, y una construccion de ácido nucleico que incluye una primera secuencia de ácido nucleico que codifica para una cadena pesada de un anticuerpo y una segunda secuencia de ácido nucleico que codifica para un dominio de union a celulosa. Reivindicacion 1: Un método para producir un anticuerpo monoclonal que comprende: a) proveer un hongo heterocarion que incluye un primer nucleo y un segundo nucleo, donde dicho primer nucleo incluye una primera construccion de ácido nucleico que incluye una primera secuencia de ácido nucleico que codifica para cadena liviana de un anticuerpo, y donde dicho segundo nucleo incluye una segunda construccion de ácido nucleico que incluye una primera secuencia de ácido nucleico que codifica para una cadena pesada de un anticuerpo, y donde por lo menos una de dichas construcciones de ácido nucleico comprende además una segunda secuencia de ácido nucleico que codifica para un polipéptido o para una parte funcional del mismo secretada normalmente por un hongo; b) cultivar el hongo heterocarion bajo condiciones apropiadas para la expresion de las cadenas livianas y pesadas del anticuerpo.It refers to methods for producing a monoclonal antibody in a heterocarion fungus or in a fungal host cell. In addition, it also refers to a nucleic acid construct, a first nucleic acid sequence encoding a light chain of an antibody, and a third nucleic acid sequence encoding a heterologous signaling peptide for the first acid sequence nucleic, a nucleic acid construct comprising a first nucleic acid sequence encoding an antibody heavy chain and a third nucleic acid sequence encoding a heterologous signaling peptide of the first nucleic acid sequence, a nucleic acid construct nucleic acid comprising a first nucleic acid sequence encoding a light chain of an antibody and a second nucleic acid sequence encoding a cellulose binding domain, and a nucleic acid construct that includes a first nucleic acid sequence which codes for a heavy chain of an antibody and a second s nucleic acid frequency encoding a cellulose binding domain. Claim 1: A method of producing a monoclonal antibody comprising: a) providing a heterocarion fungus that includes a first nucleus and a second nucleus, wherein said first nucleus includes a first nucleic acid construct that includes a first nucleic acid sequence encoding for light chain of an antibody, and wherein said second nucleus includes a second nucleic acid construct that includes a first nucleic acid sequence encoding a heavy chain of an antibody, and wherein at least one of said nucleic acid constructs comprises furthermore a second nucleic acid sequence encoding a polypeptide or a functional part thereof normally secreted by a fungus; b) cultivate the heterocarion fungus under appropriate conditions for the expression of the light and heavy chains of the antibody.

ARP050100209A 2004-01-21 2005-01-20 PRODUCTION OF A MONOCLONAL ANTIBODY IN A HETEROCARION FUNGI OR A FUNGAL GUEST CELL AR047440A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400077 2004-01-21
DKPA200400174 2004-02-05
DKPA200400761 2004-05-12

Publications (1)

Publication Number Publication Date
AR047440A1 true AR047440A1 (en) 2006-01-18

Family

ID=34811629

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100209A AR047440A1 (en) 2004-01-21 2005-01-20 PRODUCTION OF A MONOCLONAL ANTIBODY IN A HETEROCARION FUNGI OR A FUNGAL GUEST CELL

Country Status (7)

Country Link
EP (1) EP1711529A1 (en)
JP (1) JP2007535913A (en)
AR (1) AR047440A1 (en)
AU (1) AU2005206251A1 (en)
CA (1) CA2553731A1 (en)
TW (1) TW200540185A (en)
WO (1) WO2005070962A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1583830T1 (en) 2003-01-07 2006-12-31 Symphogen As Method for manufacturing recombinant polyclonal proteins
PT1729797E (en) 2004-03-22 2008-12-17 Solvay Pharm Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
CA2616943C (en) 2005-07-29 2016-04-12 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
CA3081308C (en) 2006-12-21 2024-02-20 Novozymes A/S Lipase variants for pharmaceutical use
US20100062491A1 (en) * 2007-01-05 2010-03-11 Novozymes A/S Overexpression of the Chaperone BIP in a Heterokaryon
EP2358878B1 (en) 2008-11-20 2014-10-15 Novozymes Inc. Polypeptides having amylolytic enhancing activity and polynucleotides encoding same
CN102300986A (en) 2008-12-04 2011-12-28 诺维信股份有限公司 Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same
CN102625833A (en) 2009-07-24 2012-08-01 诺维信公司 Carbohydrate oxidases
BR112012006847A2 (en) 2009-10-29 2015-09-08 Novozymes As polynucleotide polypeptide, recombinant host cell, methods for producing the polypeptide for producing a parent cell mutant, for inhibiting expression of a polypeptide, for producing a protein, for degrading or converting a cellulosic material, for producing a fermentation product, for produce a fermentation product and to ferment a cellulosic material, transgenic plant, part of the plant or plant cell, double stranded inhibitory RNA molecule, and, composition.
CN103068989B (en) 2010-06-25 2015-09-09 诺维信公司 There are the polynucleotide of promoter activity
CN103068978B (en) 2010-06-25 2017-01-18 诺维信公司 Polynucleotides having leader sequence function
US8735563B2 (en) 2010-06-25 2014-05-27 Novozymes A/S Polynucleotides having promoter activity
CN105420267A (en) 2010-11-30 2016-03-23 诺维信股份有限公司 Promoters for expressing genes in a fungal cell
US8924138B2 (en) 2010-12-07 2014-12-30 Vnomics Corp. System and method for measuring and reducing vehicle fuel waste
WO2012098246A1 (en) 2011-01-20 2012-07-26 Novozymes A/S Expression of plant peroxidases in filamentous fungi
EP2527432A1 (en) 2011-05-23 2012-11-28 Novozymes A/S Bi-directional cytosine deaminase-encoding selection marker
EP2527448A1 (en) 2011-05-23 2012-11-28 Novozymes A/S Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi
IN2014CN04586A (en) 2011-11-25 2015-09-18 Novozymes As
KR101660580B1 (en) 2014-04-02 2016-09-28 프레스티지 바이오파마 피티이. 엘티디. A method for preparing an antibody by controlling a sugar content of the antibody
WO2018165594A1 (en) 2017-03-10 2018-09-13 Bolt Threads, Inc. Compositions and methods for producing high secreted yields of recombinant proteins
JP7237365B2 (en) 2017-03-10 2023-03-13 ボルト スレッズ インコーポレイテッド Compositions and methods for producing high secretory yields of recombinant proteins
WO2019046703A1 (en) 2017-09-01 2019-03-07 Novozymes A/S Methods for improving genome editing in fungi
EP4118195A1 (en) 2020-03-12 2023-01-18 Novozymes A/S Crispr-aid using catalytically inactive rna-guided endonuclease
WO2022042673A1 (en) * 2020-08-28 2022-03-03 江苏恒瑞医药股份有限公司 Signal peptide for reducing end heterogeneity of heterologous polypeptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5643745A (en) * 1994-02-03 1997-07-01 University Of Hawaii Heterologous dimeric proteins produced in heterokaryons
US5683899A (en) * 1994-02-03 1997-11-04 University Of Hawaii Methods and compositions for combinatorial-based discovery of new multimeric molecules
DK1495055T3 (en) * 2002-04-18 2013-11-11 Genencor Int PRODUCTION OF FUNCTIONAL ANTIBODIES IN FILAMENTOUS FUNGI
JP2007506405A (en) * 2003-02-06 2007-03-22 ノボザイムス アクティーゼルスカブ Expression of human heavy chain antibody in filamentous fungi
WO2007045248A1 (en) * 2005-10-17 2007-04-26 Novozymes A/S Use of fungal mutants for expression of antibodies

Also Published As

Publication number Publication date
CA2553731A1 (en) 2005-08-04
JP2007535913A (en) 2007-12-13
TW200540185A (en) 2005-12-16
AU2005206251A1 (en) 2005-08-04
WO2005070962A1 (en) 2005-08-04
EP1711529A1 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
AR047440A1 (en) PRODUCTION OF A MONOCLONAL ANTIBODY IN A HETEROCARION FUNGI OR A FUNGAL GUEST CELL
PE20210844A1 (en) CONTORSBODIES 2 + BI-SPECIFIC
CO5601037A2 (en) ANTI-A BETA ANTIBODIES AND ITS USES
CY1122250T1 (en) ANTIBODIES DIRECTED AGAINST HER-3 AND USES THEREOF
CL2021002742A1 (en) A prevotella and francisella crispr protein 1 (cpf1) isolated from francisella tularensis; fusion protein comprising it; nucleic acid; vector; methods for altering the genome of a cell or a double-stranded DNA molecule in vitro using such proteins (divisional de sol. 201903004)
CY1119647T1 (en) ALUMINUM ACCESSORIES AND ACCESSORIES FOR ACCESSORIES
WO2006114308A8 (en) Carrier for targeting nerve cells
PE20091004A1 (en) HUMAN C-FMS ANTIGEN BINDING PROTEINS
DK0894126T3 (en) Alkaline phosphatase-deficient filamentous fungus
CU23791A3 (en) METHOD FOR THE PRODUCTION OF IMPROVED PROTEINS AND ANTIBODIES
WO2006089230A3 (en) Human monoclonal antibodies to prostate specific membrane antigen (psma)
PE20150605A1 (en) ACTIVABLE ANTIBODIES THAT JOIN THE RECEPTOR OF THE EPIDERMAL GROWTH FACTOR
EA201491599A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
AR053053A1 (en) VECTOR
AR077879A1 (en) DIRECTED IMMUNOCATE PLAYERS
WO2006041934A3 (en) Methods and compositions for improving recombinant protein production
DE602006019050D1 (en) POLYPEPTIDES WITH CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES THAT CODE
CL2008003784A1 (en) Humanized anti-hepatitis c virus e2 protein antibody or binding fragment; nucleic acid that encodes it; vector and host cell comprising said nucleic acid; method of producing the antibody; pharmaceutical composition comprising the antibody
UY38803A (en) PROTEINS INCLUDING CALICREIN-RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND USES
EA201491575A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
AR066406A1 (en) CHEMICAL PLANT DEFENSIN
AR109451A1 (en) COMPOSITIONS AND METHODS TO PREPARE ANTIBODIES BASED ON THE USE OF EXPRESSION IMPROVERS LOCI
NI201800113A (en) HUMANIZED ANTI-BASIGIN ANTIBODIES AND THE USE OF THEM.
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins
AR093778A1 (en) BINDING PROTEINS OF ANTIGENO ANTI-HER3 / HER4 OF UNION TO FORK b OF HER3 AND TO FORK b OF HER4

Legal Events

Date Code Title Description
FB Suspension of granting procedure